Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Ascent Pharmaceuticals, Inc. Patents
Assignee:
Ascent Pharmaceuticals, Inc.
Address:
Billerica, MA
No. of patents:
8
Patents:












Patent Number Title Of Patent Date Issued
5684038 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity rea November 4, 1997
A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amid
5684037 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity rea November 4, 1997
A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amid
5672358 Controlled release aqueous emulsion September 30, 1997
A controlled release aqueous emulsion is disclosed, as are its method of manufacture and use as a vehicle for delivering medicaments in liquid form. A contemplated emulsion comprises an oil-in-water emulsion having an average oil particle size of about 100 nm to about 250 nm, a pH value
5626879 Terfenadine oral granules May 6, 1997
The present invention contemplates a dry, granular terfenadine composition. That composition comprises (i) particulate terfenadine and (ii) a polyethylene oxide-polypropylene oxide-polyethylene oxide block copolymer having an HLB number of 24 that is a wetting agent for the terfenadine
5576346 Process for treating uremic pruritus November 19, 1996
A process and pharmaceutical composition for treatment of uremic pruritus in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or disper
5552436 Process for treating hemangioma September 3, 1996
A process and pharmaceutical composition for treatment of hemangioma in humans is disclosed. The pharmaceutical composition comprises a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or dispersed in a
5532270 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity rea July 2, 1996
A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amid
5455049 Terfenadine oral powder October 3, 1995
The present invention contemplates a dry, powdered terfenadine composition. That composition comprises(a) a mixture of:(i) about 1 to about 20 parts by weight micronized terfenadine and(ii) about 0.2 to about 10 parts by weight a polyethylene oxide-polypropylene oxide-polyethylene oxide bloc

 
 
  Recently Added Patents
Weight-balanced polygonal mirror, light scanning unit using the polygonal mirror, and image forming apparatus
Topical antibiotic composition for the prevention of Lyme disease
Gas flow indicator
Visualization of information associated with applications in user interfaces
Ice tray for refrigerator
Supply voltage generating circuit and semiconductor device having the same
Method for implementing dynamic pseudorandom keyboard remapping
  Randomly Featured Patents
Flash memory cell process using a hardmask
Projection device
Optical plate, backlight assembly and display device having the optical plate
MES/MIS FET with split-gate RF input
Method and device for operating an internal combustion engine
Aircraft
Pull chain device
Image forming apparatus and method for setting the conveying speed for paper sheets
Finger ring
Method of and base station for controlling beam forming in a mobile cellular network